Is Evidence of Generic Industry Skepticism Enough to Preclude a Finding of a Motivation to Combine?
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
AURIS HEALTH, INC., v. INTUITIVE SURGICAL OPERATIONS, INC.,
Before Dyk, Prost, and Reyna. Appeal from the Patent Trial and Appeal Board (PTAB).
Summary: Evidence of generic industry skepticism cannot, by itself, form the basis to preclude a finding of motivation to combine.
Auris Health requested Inter Partes Review of a patent directed to a robotic surgery system with a servo-pulley mechanism that allows surgeons to remotely manipulate and quickly swap out surgical instruments using a controller, thereby reducing surgery time. Auris argued that the challenged claims were obvious over the combination of two patent publications called Smith and Faraz. Auris argued that a skilled artisan would have been motivated to combine Smith and Faraz to decrease the number of assistants needed for the surgery and robotize some tasks. The patent owner responded that a skilled artisan would not have been motivated to combine Smith and Faraz as the “surgeons were skeptical about performing robotic surgery in the first place.” The Board agreed that the combination of Smith and Faraz disclosed every limitation of the challenged claims. However, the Board concluded that a skilled artisan would not have been motivated to combine those references because of the general skepticism about using robotic systems during surgery at the time of the invention. Auris appealed.
The Federal Circuit vacated and remanded the Board’s decision. The Federal Circuit held that, while specific evidence of skepticism in the industry related to a specific combination of references may be used in a motivation-to-combine analysis, evidence of generic industry skepticism alone cannot preclude a finding of motivation to combine. The Federal Circuit held that the Board “impermissibly” relied on the patent owner’s expert testimony on general skepticism for performing telesurgery in finding a lack of motivation to combine. The Federal Circuit therefore remanded for the Board to determine whether the evidence was sufficient to establish a motivation to combine.
Judge Reyna dissented, arguing that the majority’s finding announces a new inflexible and rigid legal principle that it is “impermissible” to consider evidence of artisan’s skepticism towards a field in determining motivation to combine.
Editor: Paul Stewart
Written by: Geetha Durairaj, Ph.D. & Kendall Loebbaka
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…